Depression News

CHICAGO — Vitamin D levels may be associated with mental health — particularly, depressive symptoms, according to research presented at the annual NUTRITION meeting.

Twenty percent of pregnant women reported using CBD-only products during pregnancy despite limited available data on potential adverse outcomes of CBD, according to findings published in Obstetrics & Gynecology.

Clearmind Medicine, a clinical-stage biotech company, has attained exclusive global rights to develop, produce and commercialize compounds designed to treat PTSD and other mental health conditions, according to a press release.

NEW YORK — Children and adolescents experience substantial racial and ethnic disparities in depression care that require interventions to address, according to a poster presented at the American Psychiatric Association Annual Meeting.

People in sexual and gender minority groups were more likely to experience loneliness and have a lack of social and emotional support, results published in MMWR showed.

A digital app was effective at improving mental health outcomes like anxiety and depression in a cohort of patients with rheumatoid arthritis, according to a speaker at EULAR 2024 Congress.

Veterans who were paired with service dogs demonstrated lower PTSD symptom severity, anxiety and depression, a study published in JAMA Network Open showed.

Discontinuation symptoms occurred in one in three people who stopped taking antidepressants, and in one in six people who discontinued placebo, according to research published in The Lancet Psychiatry.

The FDA has granted an expanded indication for BrainsWay’s Deep Transcranial Magnetic Stimulation system for depression treatment in patients aged 22 to 86 years, according to a company press release.

Patients with cancer who received specialized mental health support experienced improved quality of life, as well as reduced pain, depression and fatigue.